Identification of zinc-alpha-2-glycoprotein binding to clone AE7A5 antihuman EPO antibody by means of nano-HPLC and high-resolution high-mass accuracy ESI-MS/MS

Journal of Mass Spectrometry

Volumn 43, Issue 7, 2008, Pages 916-923

  Reichel, Christian ^a  

^a ARC SEIBERSDORF RESEARCH GMBH   (Austria)

Author keywords

Clone AE7A5; Doping control; Erythropoietin; Nonspecific binding; Proteomics; Zinc alpha 2 glycoprotein

Indexed keywords

AMINES; COLLOIDS; CONCENTRATION (PROCESS); DIFFUSERS (OPTICAL); ELECTROPHORESIS; GELATION; GELS; GLYCOPROTEINS; LEAD; MOLECULAR BIOLOGY; PROTEINS; SENSITIVITY ANALYSIS; SEPARATION; ZINC; ZINC SULFIDE;

CARRIER (CO); CONCENTRATION (COMPOSITION); ERYTHROPOIETIN (EPO); ESI MS MS; HIGH RESOLUTIONS; INTACT PROTEINS; ISOELECTRIC FOCUSING (IEF); MASS ACCURACY; NONSPECIFIC BINDINGS; PEPTIDE SEPARATION; PEPTIDE SEQUENCING; PH RANGE; PROTEOMICS; SDS-PAGE;

CLONING;

ALPHA2 GLYCOPROTEIN; AMPHOLYTE; ERYTHROPOIETIN ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AE7A5; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT PROTEIN; ZINC ALPHA2 GLYCOPROTEIN;

ACCURACY; AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; CLONE; CONCENTRATION RESPONSE; ELECTROSPRAY MASS SPECTROMETRY; ELUTION; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; URINALYSIS; WESTERN BLOTTING;

ANIMALS; BINDING SITES, ANTIBODY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPING IN SPORTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROPOIETIN, RECOMBINANT; HUMANS; MICE; NANOTECHNOLOGY; PROTEOMICS; SEMINAL PLASMA PROTEINS; SEQUENCE ANALYSIS, PROTEIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 47749093921     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1444     Document Type: Article

References (20)

1. Lasne F, de Ceaurriz J. Recombinant erythropoietin in urine. Nature 2000; 405: 635.
2. Rabin OP, Lasne F, Pascual JA, Saugy M, Delbeke FJ, Van Eenoo P. New urinary EPO drug testing method using two-dimensional gel electrophoresis. Clinica Chimica Acta 2006; 373: 186.
3. Franke WW, Heid H. Pitfalls, errors and risks of false-positive results in urinary EPO drug tests. Clinica Chimica Acta 2006; 373: 189.
4. Beullens M, Delanghe JR, Bollen M. False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise. Blood 2006; 107: 4711.
5. Lasne F. No doubt about the validity of the urine test for detection of recombinant human erythropoietin. Blood 2006; 108: 1778.
6. Catlin D, Green G, Sekera M, Scott P, Starcevic B. False-positive EPO test concerns unfounded. Blood 2006; 108: 1778.
7. Catlin D, Nissen-Lie G, Howe C, Pascual JA, Lasne F, Saugy M. WADA Technical Document TD2007EPO, http://www.wada-ama.org/en/ [Accessed 2008].
8. Lasne F, Martin L, Crepin N, de Ceaurriz J. Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Analytical Biochemistry 2002; 311: 119.
9. Lasne F. Double-blotting: a solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. Journal of Immunological Methods 2003; 276: 223.
10. SERVA Electrophoresis GmbH. SERVA ICPL kit instruction manual, 2006; www.serva.de [Accessed 2008].
11. Agilent Technologies. In-solution tryptic digestion. Agilent Nanospray and HPLC-Chip/MS Protein Identification Solutions, Agilent Technologies, Inc.: Santa Clara, CA, USA, 2005; 67.
12. Bakalarski CE, Haas W, Dephoure NE, Gygi SP. The effects of mass accuracy, data acquisition speed, and search algorithm choice on peptide identification rates in phosphoproteomics. Analytical and Bioanalytical Chemistry 2007; 389: 1409.
13. Yates JR, Carmack E, Hays L, Link AJ, Eng JK. Automated protein identification using microcolumn liquid chromatography-tandem mass spectrometry. Methods in Molecular Biology 1999; 112: 553.
14. Sue JM, Sytkowski AJ. Site-specific antibodies to human erythropoietin directed toward the NH2-terminal region. Proceedings of the National Academy of Sciences of the United States of America 1983; 80: 3651.
15. Sytkowski AJ, Fisher JW. Isolation and characterization of an anti-peptide monoclonal antibody to human erythropoietin. Journal of Biological Chemistry 1985; 260: 14727.
16. Kennedy MW, Heikema AP, Cooper A, Bjorkman PJ, Sanchez LM. Hydrophobic ligand binding by Zn-alpha 2-glycoprotein, a soluble fat-depleting factor related to major histocompatibility complex proteins. Journal of Biological Chemistry 2001; 276: 35008.
17. Takagaki M, Honke K, Tsukamoto T, Higashiyama S, Taniguchi N, Makita A, Ohkubo I. Zn-alpha 2-glycoprotein is a novel adhesive protein. Biochemical and Biophysical Research Communications 1994; 201: 1339.
18. Freije JP, Fueyo A, Uría J, López-Otín C. Human Zn-alpha 2-glycoprotein cDNA cloning and expression analysis in benign and malignant breast tissues. FEBS Letters 1991; 290: 247.
19. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, Arthur JM. Urine biomarkers predict the cause of glomerular disease. Journal of the American Society of Nephrology 2007; 18: 913.
20. Sánchez LM, López-Otín C, Bjorkman PJ. Biochemical characterization and crystalization of human Zn-alpha2-glycoprotein, a soluble class I major histocompatibility complex homolog. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 4626.